Cargando…

ABO isohemagglutinin titration or hemolysin test: what should we do to reduce the risk of passive hemolysis?()

Detalles Bibliográficos
Autor principal:	Castilho, Lilian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2015
Materias:	Scientific Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519703/ https://www.ncbi.nlm.nih.gov/pubmed/26190422 http://dx.doi.org/10.1016/j.bjhh.2015.04.002

Ejemplares similares

Prophylactic strategies for acute hemolysis secondary to plasma-incompatible platelet transfusions: correlation between qualitative hemolysin test and isohemagglutinin titration
por: Landim, Cinthia Silvestre, et al.
Publicado: (2015)

COVID-19 vaccine: what are we doing and what should we do?
por: Candelli, Marcello
Publicado: (2022)

Revisiting the diagnosis of ‘resistant hypertension’: what should we do nowadays’
por: Alsharari, Reem, et al.
Publicado: (2021)

Pregnancy in sickle cell disease – do we know what to expect?()
por: Fertrin, Kleber Yotsumoto
Publicado: (2014)

Compound heterozygosity for hemoglobin S and D: what do we need to know?()
por: Bonini-Domingos, Claudia Regina
Publicado: (2016)

Fetal hemoglobin and hemolysis markers in sickle cell anemia()
por: Colella, Marina Pereira, et al.
Publicado: (2015)

Applying molecular immunohematology discoveries to daily transfusion practice
por: Castilho, Lilian
Publicado: (2012)

The severity of illness and inflammatory markers cannot predict red blood cell alloimmunization in cancer patients
por: Castilho, Lilian
Publicado: (2013)

Red blood cell storage and alloimmunization: a fact or a myth?()
por: Castilho, Lilian
Publicado: (2015)

Blood group polymorphisms in Brazil()
por: Castilho, Lilian
Publicado: (2016)

What do we do and how do we do it? Assessing genetic counselling in the modern era
por: Yeates, Laura, et al.
Publicado: (2020)

COMPARATIVE KINETICS OF HEMOLYSIS INDUCED BY BACTERIAL AND OTHER HEMOLYSINS
por: Bernheimer, Alan W.
Publicado: (1947)

Titers of ABO antibodies in group O blood donors: patient safety and blood product supply remain a challenge
por: Denomme, Gregory
Publicado: (2011)

COVID-19 and cancer: do we really know what we think we know?
por: Robinson, Andrew G., et al.
Publicado: (2020)

Cancer and COVID-19: what do we really know?
por: Poortmans, Philip M, et al.
Publicado: (2020)

Polio eradication: what kind of world do we want?
por: Thompson, Kimberly M
Publicado: (2022)

Basal insulin titration by the app
por: Vangoitsenhoven, Roman, et al.
Publicado: (2023)

Hemolysis: A positive agglutination reaction while studying titration of anti A/B antibody for ABO-incompatible solid organ transplants
por: Arora, Satyam, et al.
Publicado: (2015)

Should we splint traumatised primary teeth?
por: Deery, Chris
Publicado: (2023)

Reticulocyte parameters: why should clinical laboratories evaluate and report them?
por: Proto-Siqueira, Rodrigo
Publicado: (2014)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Nudging to donate organs: do what you like or like what we do?
por: Beraldo, Sergio, et al.
Publicado: (2021)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

What do we talk about when we talk about rhythm?
por: Obleser, Jonas, et al.
Publicado: (2017)

The upcoming flu seasons: how worried should we be?
por: Kayali, Ghazi
Publicado: (2022)

Myeloid leukemia: are we getting better?()
por: Hamerschlak, Nelson
Publicado: (2015)

Two residues in Staphylococcus aureus α-hemolysin related to hemolysis and self-assembly
por: Du, Yufeng, et al.
Publicado: (2018)

Should we worry about the accumulation of microplastics in human organs?
por: Sorci, Gabriele, et al.
Publicado: (2022)

Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation
por: Martino, Rodrigo, et al.
Publicado: (2021)

Canada 2010: what should global health expect?
por: Horton, Richard
Publicado: (2009)

Rational use of blood: how to do it?
por: Moraes-Souza, Helio
Publicado: (2013)

Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?
por: Caimi, Paolo F., et al.
Publicado: (2014)

Hodgkin's lymphoma in developing countries: can we go further?()
por: Gaiolla, Rafael Dezen
Publicado: (2017)

Medical Students Who Do Not Match to Psychiatry: What Should They Do, and What Should We Do?
por: Balon, Richard, et al.
Publicado: (2020)

Multinational monkeypox outbreak: what do we know and what should we do?
por: Memariani, Mojtaba, et al.
Publicado: (2022)

National neonatal screening program for hemoglobinopathies: how far have we advanced?()
por: da Fonseca, Silvana Fahel
Publicado: (2014)

Comments on 'clinical course of 63 children with hereditary spherocytosis: a retrospective study' - with the particular question: 'Should HS be treated the same way throughout the world?'
por: Bolton-Maggs, Paula
Publicado: (2012)

Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?
por: Supady, Alexander, et al.
Publicado: (2021)

Use of the derived isohemagglutinin parameter to predict patients with COVID-19 in need of an intensive care unit
por: Güven, Bülent Barış, et al.
Publicado: (2022)

We need to talk more about transfusion-transmitted malaria in Plasmodium vivax endemic areas()
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m5h25rfscus77fe8tjnn0359sb